China approves Livzon Pharmaceutical's COVID vaccine as a booster
With COVID cases on the rise in China, the government has approved Livzon Pharmaceutical's COVID-19 vaccine as a booster, in hopes of having as many people boosted as possible.
COVID at-home tests: White House reports surge in demand as federal distribution stops
The Biden administration pledged that it will do everything it can to get Americans at-home COVID-19 tests following the shut down of a free federal program.
CDC approves updated COVID-19 vaccines targeting omicron variant
The Centers for Disease Control and Prevention gave final approval to updated COVID-19 vaccines targeting the dominant omicron variant on Thursday.
Eight times this conservative think tank was ahead of media, health officials on key COVID-19 facts
The conservative think tank Just Facts promoted research during the coronavirus pandemic at least eight times that was at first dismissed but ultimately shown to be correct.
Goldman Sachs lifts COVID vaccine requirement, others for employees
Wall Street banking giant Goldman Sachs said it is lifting its COVID-19 pandemic office protocols. Employees will be allowed in regardless of vaccination status.
How forced unionism hurt states during COVID
With the worst of COVID-19 behind us, states that embrace coercive unionism fared far worse than those that didn’t.
Wall Street firms set Labor Day as benchmark for return to in-office work
After more than two years of work-from-home policies, some Wall Street firms have determined it's time for employees to return to the office after Labor Day.
Biden admin provides $11M for monkeypox, smallpox vaccine production
The Department of Health and Human Services is giving around $11 million to support the first U.S.-based fill and finish manufacturing of the Jynneos vaccine.
US Open ticket sales on pace to break record with Serena Williams' final tournament
As the 2022 U.S. Open gets underway, tennis fans are coming out in droves to witness what may be Serena Williams‘ farewell performance at Arthur Ashe Stadium.
Never-ending 'pandemic' perks fueling labor shortage
Government handouts sold as pandemic relief since COVID-19 hit the U.S. in early 2020 continue to fuel shortages in the tight labor market, experts say.
Secret Service returns $286M in fraudulently-obtained COVID relief loans to SBA
The Secret Service returned $286 million in fraudulently-obtained COVID relief funds to the SBA that fell under the Economic Injury Disaster Loans.
Nearly all COVID stimulus education money approved early in 2021 remains unspent
As students enter their second full school year after the passage of the American Rescue Plan, just over 12% of its education funding has been spent.
Moderna sues Pfizer, BioNTech over COVID vaccine, alleges patent infringement
Moderna is suing Pfizer and BioNTech, alleging the companies copied its technology used to create their COVID-19 vaccine. The lawsuits were filed in Massachusetts and Germany.
Met Opera drops vaccine requirement, still mandates masks
Vaccinations will no longer be required for audiences attending the Metropolitan Opera during its next season. The Met initially made masks optional for attendees back in July.
Pfizer and BioNTech COVID vaccine 73.2% effective in children under 5, according to new data
Pfizer Inc and BioNTech's COVID vaccine was approved for use in children under 5 years old in June, and new studies have shown the vaccine to be 73.2% effective within that age group.
Working from home improves office diversity, JPMorgan CEO Dimon is wrong
Working from home has significant benefits for corporate diversity efforts. JPMorgan CEO Dimon’s return to office plan is based on incorrect information.
Instacart revenue growth accelerates ahead of planned IPO
Instacart eyes IPO as revenues grow in Q1 and Q2 increasing its valuation. Competitor Doordash's revenue increased less. Pandemic helped both companies.
Pfizer looks for US approval on updated COVID booster that targets omicron variant
Pfizer Inc and BioNTech announced on Monday that they are looking for the U.S. to approve their retooled COVID booster, which targets the omicron variant.
Novavax's COVID vaccine recommended by CDC for children aged 12 through 17
Novavax's protein-based Coronavirus vaccine has been recommended by the US CDC for adolescents aged 12-17 years old after receiving emergency use authorization for adults in June.
Adidas announces CEO Kasper Rorsted stepping down in 2023
Adidas CEO Kasper Rorsted will be stepping down from his position next year. The German-based company has already begun looking for its next chief executive.



















